DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms

PLoS One. 2013 Jul 4;8(7):e67925. doi: 10.1371/journal.pone.0067925. Print 2013.

Abstract

Epac 1 and Epac 2 (Epac1/2; exchange factors directly activated by cAMP) are multidomain proteins that mediate cellular responses upon activation by the signaling molecule cAMP. Epac1 is ubiquitously expressed, whereas Epac2 exhibits a restricted expression pattern. The gene encoding Epac2 gives rise to at least three protein isoforms (Epac2A, Epac2B and Epac2C) that exhibit confined tissue and cell specific expression profiles. Here, we describe alternative promoter usage for the different isoforms of Epac2, and demonstrate that the activity of these promoters depend on the DNA methylation status. Bisulfite sequencing demonstrated that the level of methylation of the promoters in different tissues correlates with Epac2 isoform expression. The presented data indicate that the tissue-specific expression of the Epac2 isoforms is epigenetically regulated, and identify tissue-specific differentially methylated promoter regions within the Epac2 locus that are essential for its transcriptional control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Female
  • Genes, Reporter
  • Guanine Nucleotide Exchange Factors / genetics*
  • Guanine Nucleotide Exchange Factors / metabolism
  • Hepatocytes / cytology
  • Hepatocytes / metabolism*
  • Luciferases / genetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Organ Specificity
  • Primary Cell Culture
  • Promoter Regions, Genetic*
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Signal Transduction
  • Transcription, Genetic

Substances

  • Epac protein, mouse
  • Guanine Nucleotide Exchange Factors
  • Protein Isoforms
  • Rapgef4 protein, mouse
  • Luciferases

Grants and funding

This work was supported by the National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway, the Meltzer Foundation (MB), the Swedish Diabetes Association, Family Ernfors’ Foundation, Novo-Nordisk Foundation and the Swedish Research Council (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.